Paulo Paixao (Paulo Paixão)

ResearcherID Scopus Author ID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Pharmaceutics

Clinical pharmacology and therapeutics

Molecules (Basel, Switzerland)

Universidade de Lisboa Faculdade de Farmácia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade de Lisboa Faculdade de Farmácia Sep 01 2012

Portugal

Invited Assistant Professor :: Pharmacological Sciences

Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP Oct 01 2003

Portugal

PK Assessor

Universidade Lusófona de Humanidades e Tecnologias Aug 01 2001

Portugal

Invited Assistant Professor :: Pharmacy College

University of Michigan Jun 28 2016 - Aug 24 2016

United States

Invited Assistant Researcher :: Pharmacy College

Universidade Lusófona de Humanidades e Tecnologias Aug 01 1999 - Jul 31 2001

Portugal

Invited Researcher :: Pharmacy College

Laboratório Nacional de Energia e Geologia Jun 01 1997 - Jul 01 1999

Portugal

research scholarship :: Nanoparticles and Controlled Release

Publications

Paulo Paixao, Alfredo Garcia-Arieta, Nuno Elvas Silva, Zvonimir Petric, Milton Bonelli, José Augusto Guimarães Morais, Kevin Blake, Luís Filipe Gouveia
A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European Union. Pharmaceutics 16 (5) (2024)
Paulo Paixao, Alfredo Garcia-Arieta, Nuno Elvas Silva, Zvonimir Petric, Milton Bonelli, José Augusto Guimarães Morais, Kevin Blake, Luís Filipe Gouveia
A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European Union. Pharmaceutics 16 (5) (2024)
Sara Carolina Henriques, João Albuquerque, Paulo Paixao, Luís Almeida, Nuno Elvas Silva
Alternative Analysis Approaches for the Assessment of Pilot Bioavailability/Bioequivalence Studies. Pharmaceutics 15 (5) (2023)
Zvonimir Petric, Paulo Paixao, Augusto Filipe, José Guimarães Morais
Clinical Pharmacology of Vinpocetine: Properties Revisited and Introduction of a Population Pharmacokinetic Model for Its Metabolite, Apovincaminic Acid (AVA). Pharmaceutics 15 (10) (2023)
Sara Carolina Henriques, Paulo Paixao, Luis Almeida, Nuno Elvas Silva
Predictive Potential of C max Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative ƒ 2 Similarity Factor Method. Pharmaceutics 15 (10) (2023)
Paulo Paixao, Nuno Silva, Rita Bento Guerreiro, Kevin Blake, Milton Bonelli, José Augusto Guimarães Morais, Alfredo García-Arieta, Luís Filipe Gouveia
Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union. Pharmaceutics 14 (11) (2022)
Zvonimir Petric, Joao Goncalves, Paulo Paixao
Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars. Pharmaceutics 14 (9) (2022)
Paulo Paixao, Rita Bento Guerreiro, Nuno Elvas Silva, Kevin Blake, Milton Bonelli, Jose Augusto Guimarães Morais, Alfredo Garcia-Arieta, Luís Filipe Gouveia
A Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union. Clinical pharmacology and therapeutics (2021)
Vera M S Isca, Joana Andrade, Ana Fátima Carvalho Fernandes, Paulo Paixao, Clara Uriel, Ana Maria Gómez, Noélia Duarte, Patrícia Ríjo
In Vitro Antimicrobial Activity of Isopimarane-Type Diterpenoids. Molecules (Basel, Switzerland) 25 (18) (2020)

Paulo Paixao.css-eqlu8i{font-size:small;padding-left:4px;} (Paulo Paixão)

Publication Activity (10 Years)

Top Topics

Top Venues

Paulo Paixao (Paulo Paixão)